ÂÜÀòÂÒÂ×

Rachel Hagan is an experienced professional in the field of scientific analysis and molecular biology, currently serving as the Head of Scientific Business Analysts at Sapio Sciences since November 2022. Prior to this role, Rachel held various positions at Sema4 from January 2019 to December 2022, including Clinical Laboratory Supervisor, where oversight of the whole exome sequencing team and development of project documentation were key responsibilities, and Molecular Technologist IV, focusing on next-generation sequencing processes. Rachel's career began at Yale University School of Medicine as a Research Assistant from October 2013 to January 2019. Rachel holds a Bachelor's degree in Biology from the University of New Haven, earned in 2013.